Edition:
India

Avedro Inc (AVDR.OQ)

AVDR.OQ on NASDAQ Stock Exchange Global Market

23.02USD
1:30am IST
Change (% chg)

$0.35 (+1.54%)
Prev Close
$22.67
Open
$22.80
Day's High
$23.21
Day's Low
$22.65
Volume
77,235
Avg. Vol
45,698
52-wk High
$24.74
52-wk Low
$10.76

Summary

Name Age Since Current Position

Reza Zadno

President, Chief Executive Officer, Director

Tom Griffin

Chief Financial Officer

Desmond Adler

Vice President - Engineering

Rajesh Rajpal

Chief Medical Officer

James Schuermann

2018 Chief Business Officer

Biographies

Name Description

Reza Zadno

Dr. Reza Zadno, Ph.D. is President, Chief Executive Officer, Director of the Company. He medical device entrepreneur and health care senior executive joined Avedro in 2016 to lead the company through commercialization after receiving FDA approval for its cross-linking device and drugs in the United States and to speed the clinical development of PiXL. Reza brings to Avedro deep expertise in ophthalmology as well as other life science sectors, leveraging his extensive operational and technical experience in multiple highly successful companies. Previously, Reza was the founder, president and CEO of Visiogen (acquired by Abbott), Chairman of the Board at Transcend Medical (acquired by Alcon) and Oraya Therapeutics (acquired by Zeiss). He has also been an advisor to InterWest Partners and Novartis Venture Fund. Reza has a PhD from Ecole Nationale Superieure des Mines de Paris in mechanical properties of materials and has filed more than 100 US patents.

Tom Griffin

Mr. Tom Griffin, CPA is Chief Financial Officer of the Company. He is a veteran finance executive who has spent his entire career in financial operations at medical technology and biotechnology companies. Most recently, Tom served as chief financial officer of Entellus Medical, Inc., a medical technology company that designs products for the treatment of chronic and recurrent sinusitis, for 10 years including during the company’s initial public offering before transitioning to vice president of finance in May 2016. Prior to this, he served in a variety of executive level financial positions at several organizations, including Digital Gene Technologies, Inc., Centerpulse Spine-Tech, Inc. (now Zimmer Spine, Inc.), and CIMA Labs Inc. (now owned by Teva Pharmaceutical Industries Ltd.). He is a member of Helius Medical Technologies, Inc.’s board of directors, where he is chairperson of the Audit Committee. Tom holds a BA in Accounting from the University of Minnesota, Duluth, an MBA in Management from the University of St. Thomas, and is a certified public accountant (inactive).

Desmond Adler

Dr. Desmond Adler, Ph.D., is Vice President - Engineering of the Company. Dr. Adler has a 14-year history in medical devices and telecommunications with a focus in biomedical optics and photonics. Prior to joining Avedro, Desmond was Director of Advanced Technology at St. Jude Medical where he led the development of intravascular imaging platforms for coronary artery disease. Desmond has also worked in industrial and academic research centers developing imaging technologies for ophthalmology, gastroenterology, and pulmonology. Desmond earned his PhD in Electrical Engineering and Computer Science from MIT and his BSc from the University of Alberta.

Rajesh Rajpal

Dr. Rajesh K. Rajpal , M.D. serves as Chief Medical Officer of the Company. Raj is a board certified ophthalmologist who has established an internationally recognized reputation as an expert in the fields of corneal, cataract, and refractive surgery. He is the founder of the See Clearly Vision Group and serves as Chief Medical Officer of Avedro. Dr. Rajpal is acknowledged as the first eye surgeon in the Washington, D.C. area to perform Laser Vision Correction as a principal investigator in excimer laser clinical trials. He is also one of the first investigators in the Avedro clinical studies for collagen cross linking. He currently serves on the faculty of Georgetown University and as the Cornea Consultant to the Walter Reed National Military Medical Center. Dr. Rajpal has been honored with the Senior Achievement Award by the American Academy of Ophthalmology and has previously served as President of the Washington, D.C. Ophthalmological Society. He currently serves as the Chair of the Refractive Committee of the American Academy of Ophthalmology Practicing Ophthalmologists Curriculum and on the Board of Directors of Old Dominion Eye Foundation.

James Schuermann

Mr. James (Jim) Schuermann is Chief Business Officer of the Company. He has over 20 years of global medical device experience and joined Avedro in 2018 to lead the global government affairs, health economics and reimbursement, communications, sales, field service, marketing and business development functions. Previously, Jim served as Vice President and General Manager of Mechanical Circulatory Support (MCS), a $300M business unit of Medtronic comprised of legacy HeartWare and related ventricular assist device (VAD) systems. HeartWare was acquired by Medtronic for $1.1B in 2016. Prior to the acquisition, Jim served as HeartWare’s Senior Vice President, Sales and Marketing, where he grew revenue from initial commercial launch to $277M via global expansion into 42 countries. He also spent nearly a decade at Boston Scientific where he held several sales and marketing leadership roles, eventually reaching global Director of Marketing of the company’s $235M Endourology franchise. He is a member of Lumicell, Inc.’s Board of Directors, an industry leader in the field of image-guided cancer surgery. Jim holds a B.S. in Marketing from Indiana University and an M.B.A. in Finance and General Management from Golden Gate University.